REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised)
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study. This gene therapy...
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study. This gene therapy...
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.This gene therapy is...
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.This gene therapy is...
Opus Genetics, Inc. released positive data from a pediatric cohort in an ongoing phase 1/2 clinical study evaluating OPGx-LCA5, an...
A study led by UMass Chan Medical School researchers demonstrated that a gene therapy to correct a mutation that causes...
(Image Credit: AdobeStock/Artinun)Opus Genetics announced the 1-month open-label phase 1/2 results from the first pediatric patients treated with its investigational...
GENEVA — Scientific evidence documented in a series of articles presented by the World Health Organization this week highlights the...
Horizon Health Network says it's added thousands of new employees in the last fiscal year and has developed strategies to reduce ER wait...
Horizon Health Network says it's added thousands of new employees in the last fiscal year and has developed strategies to reduce ER wait...